Device company Signalife has been awarded the Frost & Sullivan 2006 Technology Innovation Award in the field of ECG Monitoring.
Signalife's signal processing technology is the heart of their ECG system, the Fidelity 100. Originally developed to read brain waves of US Air Force F-16 pilots to objectively determine their performance, Signalife's technology is focused on signal fidelity. The FDA approved Fidelity 100, allows for the recording of a high-quality ECG signal from cardiac patients who are moving.
The Frost & Sullivan award recognizes the quality and depth of a company's research and development as well as the vision and risk-taking that enabled it to undertake such an endeavor. Other recipients of the award included IBM, Philips and Honeywell.